Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -36.82M | -341.96% | $ 10.77M |
3/31/2025 | $ -47.14M | -236.13% | $ 19.96M |
12/31/2024 | $ -60.04M | -305.83% | $ 19.63M |
9/30/2024 | $ -68.35M | -337.21% | $ 20.27M |
6/30/2024 | $ -76.51M | -369.45% | $ 20.71M |
3/31/2024 | $ -79.08M | -524.66% | $ 15.07M |
12/31/2023 | $ -82.31M | -551.71% | $ 14.92M |
9/30/2023 | $ -62.97M | -592.38% | $ 10.63M |
6/30/2023 | $ -18.1M | -38.67% | $ 46.8M |
3/31/2023 | $ -7.9M | -18.26% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for CARISMA THERAPEUTICS INC is calculated as follows: FCF [ $ -36.13M ] / Revenues [ $ 11.24M ]
(=) FCF % [ -321.57% ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.88% |
median | 7.4% |
std | 19.48% |